Sarahn Wheeler1, Anna DeNoble2, Clara Wynn2, Kristin Weaver2, Geeta Swamy2, Mark Janko3, Paul Lantos3,4. 1. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, 2608 Erwin Road, Suite 210, Durham, NC, 27710, USA. sarahn.wheeler@duke.edu. 2. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Duke University School of Medicine, 2608 Erwin Road, Suite 210, Durham, NC, 27710, USA. 3. Global Health Institute, Duke University School of Medicine, Durham, NC, USA. 4. Department of Medicine and Pediatrics, Division of infectious Diseases, Duke University School of Medicine, Durham, NC, USA.
Abstract
INTRODUCTION: To reduce the risk of recurrence, women with a history of spontaneous preterm birth (PTB) are recommended to receive 17-hydroxyprogesterone caproate (17-P) injections starting by the 20th week of pregnancy. In women eligible for 17-P, we aimed to identify patient factors and geospatial locations associated with increased risk of presentation beyond 20 weeks gestation. METHODS: We conducted a secondary analysis of a retrospective cohort study including all women meeting criteria for 17-P within a single academic medical center over a 2-year period. We compared early (< 20 6/7 weeks) with late (> 21 weeks) presenters via demographics, social history, and index pregnancy outcomes using standard and Bayesian statistical models. Geospatial mapping was performed to determine residential areas with high risk for late presentation. RESULTS: Geocoded address data was available for 351 women in whom the mean gestational age at first visit was 14.9 weeks, and 63 of whom were late presenters (17.9%). Younger maternal age, current smoking, and lack of health insurance were predictors of late presentation with greater than 95% probability. Hispanic ethnicity and black race were associated with higher odds of late presentation with 87 and 69% probability, respectively. The area with the latest gestational age at presentation was located within central Durham City and to the northeast. DISCUSSION: Our study identified patient-level risk factors and geographic locations associated with presentation beyond the recommend window for 17-P initiation. These findings suggest an urgent need for intervention to improve early prenatal care initiation and a target location where such interventions will be most impactful.
INTRODUCTION: To reduce the risk of recurrence, women with a history of spontaneous preterm birth (PTB) are recommended to receive 17-hydroxyprogesterone caproate (17-P) injections starting by the 20th week of pregnancy. In women eligible for 17-P, we aimed to identify patient factors and geospatial locations associated with increased risk of presentation beyond 20 weeks gestation. METHODS: We conducted a secondary analysis of a retrospective cohort study including all women meeting criteria for 17-P within a single academic medical center over a 2-year period. We compared early (< 20 6/7 weeks) with late (> 21 weeks) presenters via demographics, social history, and index pregnancy outcomes using standard and Bayesian statistical models. Geospatial mapping was performed to determine residential areas with high risk for late presentation. RESULTS: Geocoded address data was available for 351 women in whom the mean gestational age at first visit was 14.9 weeks, and 63 of whom were late presenters (17.9%). Younger maternal age, current smoking, and lack of health insurance were predictors of late presentation with greater than 95% probability. Hispanic ethnicity and black race were associated with higher odds of late presentation with 87 and 69% probability, respectively. The area with the latest gestational age at presentation was located within central Durham City and to the northeast. DISCUSSION: Our study identified patient-level risk factors and geographic locations associated with presentation beyond the recommend window for 17-P initiation. These findings suggest an urgent need for intervention to improve early prenatal care initiation and a target location where such interventions will be most impactful.
Authors: Stephen S Crane; Robin Naples; Cindy K Grand; Sarah Friebert; Neil L McNinch; Anand Kantak; Elena Rossi; John McBride Journal: J Matern Fetal Neonatal Med Date: 2015-08-13
Authors: Rebecca J Baer; Molly R Altman; Scott P Oltman; Kelli K Ryckman; Christina D Chambers; Larry Rand; Laura L Jelliffe-Pawlowski Journal: J Matern Fetal Neonatal Med Date: 2018-04-22
Authors: Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe Journal: N Engl J Med Date: 2003-06-12 Impact factor: 91.245
Authors: Elizabeth M Stringer; Catherine J Vladutiu; Tracy Manuck; Sarah Verbiest; Arthur Ollendorff; Jeffrey S A Stringer; M Kathryn Menard Journal: Am J Obstet Gynecol Date: 2016-01-29 Impact factor: 8.661